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We are all covered from head to toe, internally and externally, by trillions of microbes without 
even realizing it. Who are these microscopic neighbors of ours? How did they come to inhabit 
every square inch of our bodies? What purpose do they serve? These are all questions that this 
paper will seek to explore and answer in the background section. Following the discussion, the 
background knowledge will be applied to a completely novel area of research: how the 
microbiome impacts ischemic stroke.  
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Background  
Trends exist all over the world in all sorts of things. As of late, modern scientific literature has 
recently been seduced and infatuated with the microbiome, the bacteria that live inside all 
organisms. As this paper will demonstrate, though, this microbial fascination isn’t without good 
reason. The aim of this background section is to give a thorough overview on the basic ideas 
behind the microbiome: what is it? Where does it come from? What does it do? And what does it 
do in diseases? At the end there will be a brief discussion on the “frontier” of microbiome 
research, so to speak, which is a growing body of evidence pertaining to the microbiome’s 
influence on the brain. At the end of this section it will hopefully become clear why the 
microbiome is a legitimate area of concern for all concerned with health and wellness and why 
the microbiome should not be ignored as a potential source of insight and treatment opportunities 
as it pertains to the various diseases that humans are faced with today.  
So what’s the big deal? 
For every single human cell in the body, there are roughly 10 microbial cells[1]. These microbes 
inhabit nearly all parts of the body, residing all over the skin, throughout the entire 
gastrointestinal tract, in the oral and nasal cavities, and just about everywhere else. In many ways 
it would be naive to argue that this microbiome, “the collective genomes and gene products of 
resident microbes living inside and on humans”, has no impact on a person’s development and 
overall health[1]. In modern scientific literature, there has been a massive wave of research 
showing the fundamental contributions of the microbiome to organisms’ daily maintenance of 
homeostasis and development of diseased states. These microbial communities commonly form 
commensal relationships with hosts, carrying out functions that are vital to host survival such as 
food digestion, prevention of pathogen proliferation, and even assist proper development of the 
innate immune system[1][8]. In other instances, specific groups of microbes or deregulation of 
normal microbiome populations can cause homeostatic dysfunction or disease[1-3][8-14].  
Even though these microbes can have a wide range of impacts on health and even though there is 
a wide range of them, it has been found that all these microbes can actually be sorted into a very 
limited number of groups. More specifically only four main bacterial phyla, groups consisting of 
hundreds of bacterial genera and species, really constitute human microbiome populations: 
Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria[15] (Table 1). Despite the 
dominance by four bacterial phyla, there is still an impressive level of diversity in the relative 
microbial compositions at different body locations[1][16]. Human skin, for example, contains 
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nearly insignificant relative abundances of Bacteroidetes relative to other body locations. 
Gastrointestinal tract studies have shown that, in both children and adults, the microbiome 
populations can be broken down to basically 2 groups; mainly composed of Bacteroidetes and 
Firmicutes, with the two phyla accounting for roughly 98% of 16s RNA sequences detected in 
the gut of mammals[1-3][17][19]. The 16s RNA (rRNA) gene is used as a small genetic marker 
(about 1.5kb in size) that has been highly conserved amongst bacterial species and phyla to allow 
for species to be distinguished from one another along with being able to classify groups of 
microbes from the same or different phyla[30].  
Phylum Main Classes Commonly examples General traits of microbes 
Actinobacteria Actinobacteria Bifdobacterium, Streptomyces, 
Nocardia 
Gram-positive with high content of G+C in DNA. 
Diverse morphologies, physiological/metabolic 
properties. Phyla includes pathogens(ie. 
Nocardia), GI commensals (ie.Bifdobacterium), 
and even microbes adapted to living in soils (ie. 
Streptomyces)[1][18] 
Bacteroidetes Bacteroidetes Bacteroides, Prevotella, 
Flavobacteria 
Gram-negative with 4 broad classes with microbes 
adapted to live in soils, seawater, and guts of 
animals. Display varied morphologies and range 
from strict aerobes to strict anaerobes. Often 
regarded as specialists of degradation of large 
organic substrates such as proteins and 
carbohydrates[1][9] 
Firmicutes Bacilli, Clostridia Clostridium, Staphylococcus, 
Enterococcus 
Gram-positive with cocci or bacillus 
morphologies. Typically display low G+C content 
in DNA. Play roles in energy resorption in the gut 
an have been implicated in many diseased states 
including obesity[1].  
Proteobacteria Gammaproteobacteria, 
Betaproteobacteria 
Escherichia, Pseudomonas, 
Helicobacter 
Gram-negative bacteria that are typically 
pathogenic in nature[20].  
Table 1:  The four predominant bacterial phyla that compose the human microbiome. 
 
Out of all of the bodily locations that host the commensals, the gastrointestinal tract has proven 
to be the most significant to human health. By most estimates, the GI tract is the clear favorite 
area of residence for our microbial neighbors, hosting over 70% of the microorganisms in the 
body[28]. While that may seem like an shocking amount, it makes sense; if a person took their 
own gut and flattened out all the villi and microvilli the structure would have a surface area of 
about 32 square meters, the floor size of a small studio apartment or about half a badminton 
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court[29]. But the GI tract doesn’t just offer the commensals a lot of real estate, it offers them lots 
of real estate that’s full of nutrients and minerals that they can use to grow, survive, and 
proliferate, making it the clear choice for microbes that are deciding what portion of the human 
body to colonize. After establishing their community in a person’s body, this overwhelming 
majority that resides in the gut plays an incredibly important role in a person’s health. All the 
previously mentioned impacts of the microbiome stem directly from this gut community in one 
way or another.  
Starting from day 1 
This begs the question of where do these microorganisms come from? Are people born with 
them? Or do they infect hosts after birth? As it turns out, the bacteria that are found inside every 
person’s gut are mainly descendants from an initial wave of microbes that colonize sterile 
newborns in the immediate moments following birth[1]. During the seconds following birth, 
hundreds, thousands, and even millions of microbe begin attempting to colonize newborn’s 
body. Studies comparing the microbiome compositions of vaginal and cesarean delivered 
newborns have shown dramatic differences between the two groups microbial populations, 
suggesting that a person’s mode of birth delivery can play a dramatic role in determining the 
constituents of their microbiomes. As Figure 1 from Dominguez-Bello(2010) shows, 
microbiomes of vaginally delivered newborns were strikingly representative of the maternal 
vaginal and intestinal microbial populations while cesarean delivered newborns displayed 
microbiome compositions similar to those of their mothers’ skin[11]. Other studies have also 
shown a markedly reduced proportion of Bifdobacterium and Bacteroidetes (“good” bacteria) in 
the gastrointestinal tracts of cesarean delivered newborns when compared to vaginally delivered 
newborns[9]. Regardless of mode of delivery, though, this initial microbial population that 
colonizes newborns has been found to distribute itself uniformly throughout the body of the 
infant, meaning that the mode of delivery of an individual will lay the foundation of all the 
body’s future microbial communities[11, 12].  
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So what happens after birth and the initial invasion of microbes? After an individual’s 
microbiome begins forming after birth, the individual’s environment and lifestyle for the rest of 
their life will shape the development of the microbiome. An example of a person’s 
environmental factor that will play a role in microbiome development is the type of food that an 
infant will first be exposed to. Many mothers are presented with the decision of whether their 
children will be breast-fed or formula-fed, but what many are unaware of while making the 
decision is that their choice will determine how their child’s microbiome will develop from the 
moment they feed them for the first time. Recent developments have led to the general belief in 
populations that being breast-fed is generally healthier for children, but not many are actually 
aware of what specific impact breast milk has on the health of a child. For starters, breast milk 
provides infants with a booster-pack of protective and beneficial goods like cytokines, growth 
factors, immunoglobulin’s, lactotransferrin, lysozymes, and human milk oligosaccharides 
(HMO’s)[13, 14]. While all the components assist in proper immune development in the infant, 
HMO’s play a particularly important role in protecting infants from disease and infection by 
acting as decoys for invading pathogens thereby preventing the infectious microbes from gaining 
access to epithelial cells[23]. What has been most surprising, however, has been the finding that 
shows that the carbohydrate-rich component essentially functions as a prebiotic in the 
microbiome by stimulating and promoting the colonization and growth by Bifdobacterium sp[23]. 
As such, multiple studies have shown that breast-fed infant actually present with much higher 
relative abundances of both Bifdobacterium and Lactobacillus (commonly considered beneficial 
bacteria) microbes in their gut microbiomes compared to formula-fed infants, who actually show 
a significantly increased rate of colonization by Clostridium and other pathogenic microbes 
(especially C dificile) which is probably attributed to the lack of protective HMO’s in their 
diets[23-25]. Not surprisingly, infants with proportions of beneficial microbes in their microbiomes 
have been shown to be better protected from allergies, diarrhea, necrotizing enterocolitis, 
Figure 1: 16s bacterial RNA UniFrac analysis 
conducted by Dominguez-Bello(2010). Unifrac 
analysis uses phylogenetic information to calculate 
and display the genomic differences amongst 
microbial communities[21]. Significant differences can 
be seen in newborns’ microbiome compositions 
depending on the baby’s mode of delivery at birth[11].   
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obesity, and even type II diabetes. It’s truly amazing to think how such a seemingly small 
decision about a baby’s first food can have such a significant impact on the development of their 
microbiome. What’s more impressive, though, is how big of an impact the resulting microbiome 
can have on the baby’s development and health later on.  
But do environmental factors have a significant impact on the microbiome only during the initial 
stages of a person’s life while the microbiome is in it’s early immature stages of development? 
Are microbial populations less affected later on in life as their diversity and population size 
increases? As it turns out, the microbiome’s sensitivity is not lost with age. In fact, the microbial 
composition can be, and is, constantly affected by various environmental factors such as a 
person’s diet. In 2006, Turnbaugh was able to rapidly and significantly alter the microbial 
compositions in mice containing human microbiomes[26]. David(2013) showed that even short-
term dietary changes can trigger dramatic compositional changes in the human microbiome by 
tracking microbial response when subjects shifted to entirely plant-based or animal-based diet. 
David(2013) showed animal-based diets significantly increased bile-tolerant microorganisms 
while decreasing the abundances of bacteria responsible for metabolizing plant polysaccharides 
(the opposite held true for microbiomes introduced to plant-based diets)[26]. The changes that the 
microbiomes experience in response to dietary changes don’t simply regress overtime, in fact, 
after initial changes occur in the microbiome, the microbiomes stabilize in their new states and 
remain stable indefinitely until a new environmental factor is introduced and they must change 
again[27].  
While only a handful were mentioned here, there are a plethora of environmental and lifestyle 
factors that can influence the development and composition of the microbiome. However, it was 
previously mentioned that when it comes to the gut, roughly 98% of resident microbes fall into 
just two main phyla of bacteria regardless of environmental changes. How can that be? Well, as 
it turns out, it’s not a mere coincidence that the invading microbes were allowed to colonize and 
reside in the gut after birth, as the following sections will shed light on, host-microbiome 
interactions play critical roles in shaping how the immune system will develop and react to 
pathogens, in prevention of the propagation of these invading microbes, and carry out processes 
so vital to human digestion and metabolism that without them malnutrition would be 
unavoidable. 
With Great Microbes Comes Great Immunity 
Instead of triggering an outburst of protective measures by the immune system, the microbial 
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residents of the gut are a critical step in proper development to the system that will ultimately 
determine the overall health of the host. The role of the microbiome in the development of the 
systemic immune system is most readily seen in studies that have focused on germ-free (GF) 
animals that lack any form of colonizing bacteria. These mice that lack the normal endogenous 
microbes have been found to contain hypoplastic Peyer's patches, the organized lymphoid 
nodules responsible for intestinal immune surveillance and generation of the intestinal immune 
response[30]. The spleens and other lymph node structures in the GF mice have also been found to 
be defectively formed or entirely functionally absent in mice lacking a proper microbiome[30]. If 
the structures that are responsible for the immune response are defective then what about their 
products and immune cells? As it turns out, those too are harmed by the lack of a microbiome 
with GF mice presenting with inadequate levels of immune cells and their products, such as IgA-
producing plasma cells and their immunoglobulins and major irregularities in circulating 
cytokine levels and profiles[31-33].  
Is it really the microbiome, or lack thereof, responsible for the immunodeficiency that occurs in 
the GF animals or is it a mere coincidence? This is the same question that was asked by 
researchers when the initial results were reported about the GF mice and to the dismay of many 
skeptics of the significance of the microbiome, specific microbial populations were found to play 
very specific roles in the modulation of immune development. Along with the previously 
mentioned deficiencies that have been reported in GF mice that lack the proper endogenous 
microbiome, the mice are also completely devoid of proper CD4+ T cell expansion[34]. These T 
cells, are mature T helper cells that are absolutely necessary for a host's immune response to 
invading pathogens[35]. Without any intervention, the GF mice would exhibit this deficiency their 
entire lives. This deficient phenotype was able to be entirely reversed through the administration 
of "good" microbes to the mice from the Bacteroidetes phyla, more specifically Bacteroides 
fragilis[34]. More strikingly, it was found that the phenotype was reversed by specific interactions 
between the administered microbes and the immune system: dendritic cells recognized specific 
epitopes present on the Bacteroidetes phyla, presented the antigens to immature T lymphocytes 
in the mesenteric lymph nodes (a required step to T cell activation and expansion), and this 
presentation ultimately caused the development and proliferation of CD4+ T cells along with the 
lymphocyte-containing compartments in the spleen[34]. The exposure and presence of just one 
specific group of microbes not only supports proper immune development, but is actually vital to 
the immune system's maturation at both a cellular and organ level.  
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Many would still attempt to argue that perhaps the immune system development can be triggered 
by any form of microbes, and there is no actual causal relationship between the microbes that are 
reported as "good" versus those that are considered harmful. A study comparing GF mice 
colonized by altered Schaedler flora (ASF) and GF mice colonized by microbial populations 
consisting of mainly Bacteroidetes phyla members showed just how important specific microbial 
populations and proportions are for proper immune development. ASF is a bacterial mix 
containing 8 bacterial species that are considered the "normal" or archetypal microbial species 
that are expected to be present in mice[36]. The mix often contains relatively equal portions of 
each group and is commonly used in studies involving the GI tract since it gives researchers an 
easily controllable and reproducible microbiome population in their studies. The mix of microbes 
in the microbiomes of ASF colonized mice, however, isn’t representative of the endogenous 
microbiomes of normal organisms. If the immune system required merely the exposure to 
microbes to trigger proper development as many microbiome skeptics would believe, then the 
ASF contains more than enough of a variety and number of microbes to trigger some sort of 
response. What was actually seen, however, was that ASF colonization wasn't sufficient to 
promote differentiation of Th17 cells, T cells necessary for immune functions such as 
recruitment, activation, and migration of neutrophils, interleukin-21/22 secretion, and anti-
microbial immunity at various epithelial barriers[37]. The GF mice colonized by microbial mixes 
found in normal endogenous microbiomes, more importantly, mixes containing high proportions 
of Bacteroidetes microbes, normal differentiation and proliferation of Th17 cells was seen[38]. 
The findings point out the importance of the specific endogenous mixes of microbes that 
commonly reside in the endogenous microbiome. The immune system has clear requirements for 
exposure to specific antigens provided by the specific microbes present in the microbiome. 
Without the proper microbial compositions, the necessary and complex interactions between 
host-microbes cannot occur and the normal development of the immune system will be severely 
hindered. 
The Great Wall of Bacteria  
The most obvious yet commonly overlooked benefit that the commensals confer to hosts is the 
physical barrier that they provide against antigens from the external environment at the intestinal 
mucosa. The most intuitive way that the endogenous microbes do this is by physically excluding 
foreign invaders. While the exact mechanisms of action have yet to be elucidated, there is a clear 
exclusion of pathogens that occurs when normal microbes colonize the GI tract. Corr(2007) was 
able to show that many bacterial strains that are commonly used in probiotic blends such as 
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Bifdobacterium and Lactobacillus  physically prevent the attachment and invasion of the  
pathogenic Listeria through the elaboration of their processes and secretion of compounds that 
induced epithelial cell immune/structural responses such as in recent reports that have described 
increased expression of tight junction proteins responsible for maintaining the integrity of 
multiple vital endothelial barriers like the blood-brain barrier following normal host-microbiome 
interactions that occur during development[39, 82]. Lactobacillus has even been shown to decrease 
the ability of pathogens E. coli and S. enteritidis to bind their attachment sites on the ileal 
mucosa[39- 41].  
But the bacterial residents don't simply buy out all the real estate in the gut to keep pathogens 
out; they're armed with weapons and are more than willing to use them to keep out unwanted 
guests. Microbes from the Lactobacillus genus are an example of of microbes that take it upon 
themselves to produce substances to directly prevent pathogenic colonization. So what do they 
do? The genus members all produce lactic acid, which creates low pH environments that greatly 
deter the growth of bacteria that are not adapted to surviving in the acidic environments[30]. Many 
other strains of bacteria normally present in the endogenous microbiome also produce substances 
that function to prevent pathogen invasion, such as the Rumminocus gnavus bacteria that produce 
lantibiotics (peptide antibiotics produced by many Gram-positive bacteria to attack other Gram-
positive invaders)[42][43]. Many of the anti-microbial substances released by endogenous 
microbiome members often either target other bacteria that are similar to themselves, a simple 
yet effective mechanism to eliminate any potential competition for niches from invading 
pathogens. Other times the production or activation of the products depends on host mechanisms 
like enzymes which further demonstrates the incredible level of co-adaptation of the microbiome 
to the host[30][53].   
Many of the microbes also help bolster host protective measures by carrying out important steps 
to induce expression of antimicrobial substances by the host or to activate anti-microbial 
precursors that the host secretes. One incredible example of this is the induction of  defensin 
expression in the GI tract. Defensins are one type of of anti-microbial peptides produced by the 
body to defend itself against bacterial, fungal, and viral infections[44]. Defensins, and multiple 
other similar substances, are produced by secretory epithelial cells (Paneth cells) that are present 
at the base of crypts in the intestinal lumen and secretion has been shown to be controlled by the 
normal endogenous microbiome[30][45]. Vaishnava(2008) showed that in order for a host to 
express full levels of antimicrobial compounds from the Paneth cells, the entire normal microbial 
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community was necessary, with reduced levels of expression in organisms lacking microbial 
phyla[47]. Looking at the same relationship from a different angle, other studies have shown that 
administration of certain bacterial species on top of the already present normal microbiome can 
even induce expression of anti-microbial substances from the GI tract cells[46, 47]. As mentioned 
earlier, some anti-microbial compounds are secreted in an inactive form by the host, many 
defensins are an example of this as they are secreted as prodefensins. These prodefensins aren't 
able to confer any protective benefits to the host until they undergo proteolytic cleavage by the 
enzyme matrilysin[30][48]. Using GF mice, Lopez-Boado(2000) was able to identify that one of the 
major factors controlling production and secretion of the enzyme is the presence and 
colonization of the GI tract by B. thetaiotaomicron bacteria, yet another member of the "good" 
Bacteroidetes phyla, which were shown to induce enzyme expression by Paneth cells[48]. Not 
only do the endogenous microbes play a critical role in causing the secretion of necessary 
protective molecules by the body to protect itself against invading pathogens, but the lack of a 
microbiome (or the lack of the proper microbiome composition) can severely hinder host 
defenses by not activating protective compounds or not activating the production of supporting 
molecules necessary for host defense. 
The Microbe Diet  
Food is something that people of all ages, genders, nationalities understand. Everyone has to eat, 
and in most cases, everyone enjoys it. But not many take the time to appreciate all the complex 
and interconnected processes that must occur in the body to absorb nutrients and convert the 
ingested organic substrates into useful energy. Studies of biochemistry and other scientific 
courses devote significant portions of time studying metabolic processes such as glycolysis, the 
citric acid cycle, and oxidative phosphorylation, making it seem as though humans possess 
incredible amounts of metabolic abilities. Without taking anything away from the complexity 
and engineering of these internal processes, the metabolic capabilities of the human body are 
actually quite pathetic without the microbiome. The genetic information that the microbiome 
contains for metabolism is far greater and far more versatile than the information encoded in the 
human genome[49]. As a result, a significant portion of metabolism and metabolic homeostasis is 
under the control of the microbiome. The importance of the microbiome to metabolism is very 
intuitive, though, since digestion and absorption occurs primarily in the area where the GI 
microbiome resides. The significance of the microbes to the processes becomes even clearer 
through the numerous studies that have shown that GF mice require a markedly increased caloric 
intake on a daily basis compared to mice containing normal, unaltered microbiomes in order to 
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maintain the same body weight[30]. So what exactly are these bacteria doing for the host? Well, 
they are vital to proper metabolism by carrying out two main functions.  
The first of the functions that the microbiome carries out for the host in terms of digestion is by 
allowing the host to have access to calories that they would normally be unable to access without 
the aid of the microbes. One mechanism in which microbes unlock otherwise indigestible 
sources of nutrients is by metabolizing large portions of dietary fiber to short-chain fatty acids 
and usable monosaccharides[50]. Not having bacteria present in the GI tract to metabolize the 
fiber would cause humans to miss out on a major energy source, but it would promote the 
production and accumulation of potentially toxic metabolic by-products by the body as a direct 
consequence of saprophytism, the process of obtaining nourishment from dissolved decaying 
organic matter, as shown by Vella(1999)[50, 51].  
Along with giving access to new energy sources, the microbiome also plays a role in promoting 
the efficient absorption of ingested nutrients. Not only have studies shown that the presence of 
the endogenous microbiome helps promote and support the activity of lipoprotein lipase in 
adipose tissue resulting in increased tissue fatty acid uptake, but administration of specific 
bacterial strands from the normal microbiome into GF mice has significantly improved nutrient 
absorption[52]. Administration of B. thetaiotaomicron to GF mice resulted in increased colipase 
expression, an important cofactor used by pancreatic lipase, which led to increases in efficiency 
of hydrolysis and absorption of ingested lipids[53]. Not only that, but an increased expression of 
the Na+/glucose cotransporter was seen in the intestine following the microbe administration and 
colonization of GF mice, also causing an increased glucose uptake by the organisms[53].  
Without the presence of the microbiome, human hosts would miss out on enormous energy 
stores stemming from the lack of genetic capability to metabolize many forms indigestible 
oligosaccharides and polysaccharides. Additionally, the absorption of nutrients that the human 
body is equipped to deal with would be greatly reduced due to the lack of assistance that is 
normally provided by the microbiome. Proper nourishment and metabolism hinges on the 
presence of the microbiome, the human diet is truly a microbe diet; without them, inefficient 
digestion and malnourishment is inevitable. 
Although this is nowhere near a full comprehensive outline of the benefits that the microbiome 
confers to the human host, it should be quite clear as to why the microbes are allowed to remain 
in the body after their initial colonization after birth. It's incredible to think of just how big of an 
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impact bacterial communities, and even simple specific bacterial antigens, have on the proper 
development and maturation of the immune system, a system which has the power to determine 
the entire course of a person's life. Along with supporting host defense development, the 
microbes even work to develop their own weapons against invading pathogens. Finally, many 
vital life-processes that an organism must carry out to survive are heavily influenced by the 
endogenous microbiome, which is best shown in the critical roles the microbial populations play 
in metabolism. 
It's not you... It's the microbes 
It's obvious now that the microbiome plays a major role in development and homeostasis 
maintenance. But the microbial populations playing such a major role in maintaining overall 
health and wellbeing in humans exposes humans to a whole new danger. The massive roles that 
the microbiome plays in various aspects of immune system development and control means that 
a loss of regulation of the microbiome itself could prove disastrous for the functions and 
processes that it regulates in the body. 
As modern science has come to realize the importance of the microbiome to the everyday health 
of a person, there has been a great deal of data that has been published comparing the 
microbiomes of healthy and diseased individuals showing that microbial compositions greatly 
vary between the two groups in numerous diseases. To date, over 25 different diseases and/or 
syndromes have been associated with specific alterations in the microbiome[54]. The implicated 
diseases range from obvious candidates such as obesity to seemingly unrelated neurological 
diseases like multiple sclerosis. In the following sections, the major health implications of the 
microbiome will be further explored in the context of a few diseases that have been shown to 
have their roots in the endogenous microbes residing in people’s guts.  
Fat Bacteria? 
Based on the metabolic roles that the microbiome plays in the human body, it doesn’t come as 
much of a surprise that one of the first diseases related to altered microbial compositions was 
obesity. Initial tests sought to compare the microbes that were present in normal “lean” mice and 
genetically obese mice by analyzing the 16s rRNA sequences in samples from the two 
microbiomes. The results showed a strikingly clear difference between the two groups in regards 
to the ratio of Bacteroidetes and Firmicutes (which make up well over 90% of the gut 
microbiome) with a dramatic decrease of about 50% in Bacteroidetes and a major proportional 
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increase in Firmicutes in obese mice when compared to lean mice[55]. Further studies using other 
murine models for obesity and even human models found the persistence of the high Firmicutes 
to Bacteroidetes ratio in organisms suffering from obesity[56].  
The clear divide between the two groups suggested that the drastically skewed ratio must signify 
some sort of molecular change in the obese mice, and Turnbaugh(2007) demonstrated the 
molecular explanation by delving deeper into the genomic differences between the “lean” 
microbiome and obesity-associated one. Compared to “lean”-microbiome containing mice, obese 
mice showed a marked elevation in genes for enzymes involved in polysaccharide digestion, 
suggesting the obese mice are simply ultra-efficient at squeezing out every last bit of energy 
from ingested food[57]. Fecal analysis confirmed the theory by demonstrating a greatly reduced 
amount of energy remaining in the feces of obese mice[57].  
The final test for the obesity-associated microbiome came in the form of microbiome transplants 
from obese mice to GF mice. After colonization of the gut of GF mice by microbiomes from 
either obese or lean donors, it was found that the obese phenotype was transmissible, meaning 
that the microbiome itself was, at least in part, directly responsible for the diseased phenotype[57, 
58]
. GF mice receiving the “obese” microbiome showed a 60% increase in fat storage and 
developed insulin-resistance after just 14 days compared to the GF mice receiving the “lean” 
microbiome[54, 57]. When the colonized GF mice were fed an obesity-inducing diet, both groups 
showed weight gain, but more impressively, the obesity-associated microbiome mice showed 
increased weight gain compared to “lean” microbiome mice and the microbiomes of “lean” mice 
actually began to shift to resemble the obesity-associated microbiome as obesity began to set 
in[57][58]. When plain GF mice lacking a microbiome of any kind were fed the same obesity-
inducing diet, however, they failed to experience any significant weight gain and never presented 
with an obese phenotype, giving further support for the microbiome-caused obesity condition[59].  
Burning Gut 
While microbes can’t literally set a person’s gut on fire, they can (and commonly do) cause the 
painful set of conditions referred to as Inflammatory Bowel Diseases (IBD). The role of the 
microbiome in IBD’s or more specifically in Crohn’s disease and ulcerative colitis, was 
elucidated in much the same way as it was in obesity: by initially comparing the microbiome of 
healthy individuals compared to those suffering from the disease. Three main common trends 
have been reported by studies seeking to explain the role of the microbiome in IBD’s: IBD 
patients have a decreased diversity and stability in their gut microbiomes, they have markedly 
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decreased amounts of microbes that commonly confer anti-inflammatory properties to the host, 
and the microbiome functions in altered or defective ways in IBD patients when compared to 
healthy individuals[54, 60].  
Many studies have attributed the initial triggering of IBD to defective mucosal barriers that 
allows for infection and colonization of portions of the gut by pathogenic bacteria like the 
Proteobacterium Mycobacterium and Klebsiella or the Actinobacteria phyla member, 
Campylobacter[61]. After invasion by the opportunistic pathogens, they begin to quickly 
propagate and severely diminish microbial diversity in the microbiome by essentially kicking out 
endogenous microbes and out-proliferating other microorganisms. Others have also reported 
elevated levels and proportions of pathogenic E. coli strains tightly bound to apical intestinal 
epithelium’s of Crohn’s disease patients[63]. IBD patients also showed greatly decreased amounts 
of Faecalibacterium prausnitzii, a bacterium that has been shown to be associated with anti-
inflammatory functions in the body by reducing the secretion of proinflammatory cytokines 
while increasing that of interleakin-10, a molecule that functions as a regulator of the immune 
system that prevents hyperactive immune responses[63, 64]. While many relationships are still 
being explored between the microbiome and IBD, there is already evidence of a causal 
relationship similar to obesity as the dysbiosis seen in the microbiome and it’s subsequent loss of 
immune regulation that occurs in IBD has been greatly reduced and improved in models of IBD 
via administration and gut colonization by anti-inflammatory microbes like Faecalibacterium 
prausnitzii[64].  
Aging as a symptom? 
While obesity and IBD are only two small examples of diseases that have been related to 
microbiome dysregulation, they point to very important points regarding the microbiome and 
health. While the environment influences and shapes the microbiome throughout life, especially 
early in life, later on the microbiome is capable of directly influencing the host and its health; the 
relationship is a two-way street, it’s bidirectional. This is shown by how various environmental 
aspects can influence the composition of the microbiome, but more importantly by how specific 
disease phenotypes can be transmitted to healthy organisms by simply transplanting and 
colonizing the healthy organism’s gut with the disease-associated microbiomes.  
What has been one of the most interesting findings in microbiome research has been the way an 
individual’s age impacts the microbiome, which is bringing in results that make age look like a 
negative symptom of a changing microbiome. What many researchers have found is that 
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microbial compositions are far from being considered static, they’re constantly changing and 
adjusting after the initial colonization with extremely dramatic changes occurring during infancy 
through adulthood[17]. When Agans(2011) sought to compare the gut microbiomes of adolescents 
to adults, for example, his results showed clear age-related microbiome differences between the 
(Figure 2)[21].  
 
Comparing samples from healthy adults and children, they found that both groups had 
microbiomes dominated by the two major phyla (Bacteroidetes/Firmicutes) as expected, but the 
microbiome of young individuals had a statistically significant increased abundance of beneficial 
Bacteroidetes bacteria and Bifdobacterium[21]. Other studies have reported similar differences in 
microbial compositions between age while showing nearly-perfect correlations between the aged 
microbiome compositions and poorer scores on frailty indices used to evaluate age-related 
clinical signs of deterioration in mice[65]. Van Tongeren(2005) was even able to correlate 
increases in frailty in older individuals with decreases in bacterial groups that were previously 
discussed as playing important beneficial roles in host health such as Lactobacillus and F. 
prausnitzii bacteria[66].  
While many of the reported data sets have been reported as correlations, it’s impressive to see 
such tight correlations between aging and specific compositional changes in the microbiome. 
What’s more interesting to think about is how aging has been shown to bring about microbiome 
changes that have been associated with disease and negative health effects, such as increases in 
“harmful” Firmicutes in proportion to Bacteroidetes, decreases in microbial diversity, and 
decreases in “beneficial” microbes associated with immune regulation and homeostatic 
maintenance[66-68] 
 
 
Figure 2: Principle component analysis of microarray data 
collected by Agans(2011) comparing healthy pre-
adolescent/adolescent children (kHLT) and healthy adult 
(aHLT). The gut microbiomes were measured and 
compared by detecting microbial 16s rRNA genes [21]. 
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The New Frontier: The Brain 
Many of the discussed diseases and health impacts related to the microbiome make sense, the 
conditions all have some sort of mechanistic and intuitive link to the gut area of the body. But 
how could the gut microbiota possibly influence other peripheral systems in neurological 
disorders? How does it influence the nervous system? While the link connecting the microbiome 
and brain has long evaded researchers, recent findings are making breakthroughs is this new 
frontier of microbiome research.  
To date, reports have been maintain containing evidence that the microbiome and the metabolites 
of its microbes play significant roles in influencing behavioral and brain processes such as stress 
responses, emotion-driven behavior, and various biochemical pathways in the brain[69]. While 
much of the evidence is still fairly new and not many causal relationships have been established, 
spending some time to review the current preclinical evidence of the gut-brain relationship is 
worthwhile due to the consistent trends found in reports and possible clinical implications of the 
findings.  
Using GF mice and microbiome transplantation, Sudo(2004) was able to show the microbiome 
plays a clear role in adult stress-responsiveness by monitoring the hypothalamic-pituitary-adrenal 
reaction to stress of GF mice to mice colonized by normal microbiomes. Not only were plasma 
levels of stress-response molecules (such as ACTH and corticosterone) significantly elevated in 
GF mice lacking microbiome compared to mice with normal microbiomes, but the GF mice 
actually presented with decreased brain-derived neurotrophic factors in the cortex and 
hippocampus[69, 70]. To follow up on the findings the research group administered “beneficial” 
bacteria in the form of Bifdobacterium to some of the GF mice and compared them to GF mice 
that were administered pathogenic E. coli finding that the GF mice receiving beneficial microbes 
demonstrated a reversal of their previously elevated response to stress while mice receiving E. 
coli presented with an even further elevated response to stress[70]. While rapid responsiveness to 
stress is essential to survival, the exaggerated and prolonged stress molecule elevation in GF 
mice is purely detrimental to the host’s health.  
But stress responsiveness wasn’t the only area of the human psyche that has been implicated in 
being impacted by the microbiome. Many other reports have shown that a link exists between the 
microbiome and depression, anxiety-linked behavior, learning and memory, and even social 
behavior[69, 71, 82]. Pathogenic bacteria and high proportions of Firmicutes have been linked to 
increased emotional behavior, increased incidences of anxiety-like phenotypes, impaired 
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learning and memory functions, and reduced social interactions and ASD-like behaviors[81-86].  
Phenotypes such as depression and anxiety have been reversed through the use of probiotics 
containing “beneficial” and normal microbial populations, seeking to push hosts’ microbiomes 
towards compositions that are normal84, 86]. A fascinating find has been made using ASD model 
mice, however, use of probiotics containing Bacteroides fragilis to behavioral and social 
improvements in mice[87].  
Other intriguing evidence has emerged from research looking at these specific phenotypes, with 
multiple studies linking the effects of diet on the microbiome to the depressed phenotype[72]. 
Meta-analyses suggested that healthy diets (more specifically Mediterranean-style diets) and the 
beneficial effects on the microbiomes, markedly reduce the incidence of depression in 
individuals and seem to confer protection against cognitive decline when compared to diets rich 
in sugars and fat, which are tightly correlated to increased psychological symptomology[73]. But 
while these results are impressive to see, are there truly any causal relationships between the 
microbiome and the depressed and anxious phenotypes? Or is it just a coincidence? Studies led 
by Bested(2013) and others sought to solve this question by seeing if psychological phenotypes, 
like other disease phenotypes, could be transmitted via microbiome transplantation and the 
results were nothing short of stunning, showing that not only could the anxious phenotype be 
transferred via gut microbiome transplantation, but manipulation of the gut microbes via 
probiotics and antibiotics can alter and reverse depressed phenotypes[74-76].  
So if these psychological phenotypes can be transferred by the microbiome then what is really 
going on a molecular level, what specific microbes are responsible? As it turns out, all the 
microbial populations that have been previously discussed as part of the normal healthy 
microbiome and those as part of the pathogenic, disease-causing group retain their respective 
roles when influencing the nervous system.  
Many of the microbes that have been described as harmful, especially elevated proportions of 
Firmicutes to Bacteroidetes, commonly compromise the tight junctions that are meant to form an 
epithelial barrier to the outside environment[77]. This disruption, commonly referred to as “leaky 
gut,” is caused by lack of proper host-microbiome interactions that have been previously 
discussed as vital to immune development and the lack of needed beneficial microbes to confer 
protective benefits against invading pathogens. When the intestinal defenses are compromised, 
bacteria-derived lipopolysaccharides (LPS) can access to system circulation and levels rise 
throughout the body triggering immune and inflammatory responses that can be tracked by rising 
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levels of pro-inflammatory cytokines throughout the body[78]. This sort of inflammation has been 
implicated as one of the causative factors of depressive symptoms, as demonstrated by studies 
that have found high levels of immunoglobulins against bacterial LPS circulating in the plasma 
in patients suffering from chronic depression[79]. In animal models researchers have even been 
able to induce the depressed phenotype by prolonged administration of LPS, which can be 
reversed through administration of anti-depressants[79]. Along with sending molecules into 
circulation, those suffering from leaky gut are also prone to experiencing microbial translocation 
across epithelial boundaries that would normally be impermeable to bacteria, which has been 
shown to trigger autoimmune responses by immune systems that target intestinal serotonin and 
its receptors, culminating in increased feelings of fatigue and illness behavior in patients[80].  
Another impressive recent development in the search for the link between the gut and the brain 
has been the work of Brainiste(2014) which has shown that the lack of the normal endogenous 
microbiome actually functions to increase permeability of the blood-brain barrier, thereby giving 
potentially harmful metabolites of immune responses and pathogenic microbes access to the 
brain itself[82]. There have even been links made between brain development and the microbiome 
such as GF mouse models displaying decreased brain-derived neurotrophic factor in the 
hippocampus, altered expression of GABA A and B subunits, and altered expression of NMDA 
receptor subunits[88, 90]. Other studies have found that abnormal microbial compositions can 
actually decrease the abundance of proteins needed for proper brain development such as PSD-
95 and synaptophsin in the brain[90].   
While this discussion won’t be able to give a full explanation and run-down of the discussed 
studies and the exact molecular mechanisms responsible for the microbiome induced effects on 
the brain one point should be clear: they definitely exist. While many precise causal relationships 
are still yet to be found, the tight correlations are starting to show the growing importance of the 
microbiome to all aspects of health. Not only are the microbes affecting systems in the gut, but 
abnormal and pathogenic microbes can, and do, have very negative effects on peripheral systems 
throughout the body, going as far as the brain to affect the host’s psyche and neural development.  
 
The microbiome and its effects on the human body are both varied and complex. But it cannot be 
denied that a relationship between the two exists. Not only does it play a vital role in 
development throughout life, it can ultimately affect the host’s health and wellbeing. While 
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many are often quick to write-off studies relating the microbiome to various diseases, modern 
scientific literature shows that it’s undeniable that the endogenous commensals are involved on 
some level in nearly all human diseases. This basic belief was what prompted the study that will 
be discussed in later sections. 
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Introduction 
Each year, nearly 800,000 individuals residing in the United States will have a stroke. Of these, 
about 130,000 cases will prove fatal while many of the survivors will be forced to live with 
disability for the remainder of their lives. Out of all strokes over 87% are ischemic strokes. An 
ischemic stroke, in the most basic sense, is the initiation of the ischemic cascade in response to a 
loss of blood supply to a part of the brain. The lack of oxygen due to a lack of blood to neurons 
severely hinder the cells' abilities to synthesize ATP through normal processes which forces cells 
to switch to anaerobic metabolism. While anaerobic metabolism can generate sufficient levels of 
ATP for basal levels of survival for very brief periods of time, it is in no way prepared to sustain 
cellular life for the time frames that are involved in strokes, which can last from minutes to 
several hours. This energy failure will ultimately result in the slowing and failure of ATP- 
dependent ion pumps in neurons that are absolutely vital for survival. Pump failure will lead to 
cell depolarization and excess neurotransmitter release. At the cellular level, this cascade will 
culminate in the production of harmful free radicals, reactive oxygen species, and the over 
activation and production of ion-dependent enzymes resulting in the breakdown of the cell's 
components and cell death. If, or when, the brain is re-perfused, the tissue will experience further 
injury on the macro scale due to a sweeping inflammatory response to cell damage, damage to 
the blood-brain barrier, and rampant edema. The widespread incidence of this debilitating 
condition costs the United States an estimated $36.5 billion dollars every single year. Despite 
this, clinicians are armed with very little to combat the disease. 
Recent research developments have brought about the rise in awareness about the importance of 
the microbiome, the various gut flora present in all organisms, in relation to disease prevention, 
management, and treatment. Many of the risk factors for stroke including high blood pressure, 
obesity, and diabetes have been found to be not only affected by the microbiome, but can also be 
changed, altered, and even reversed by changing the microbiome itself. Alterations in microbial 
diversity can increase the risk of many diseases ranging from obesity to multiple sclerosis to 
aging, but changes in the microbiome after ischemic stroke have not yet been examined. In 
addition, it is unknown if changes in the microbiome can influence either stroke severity or 
stroke recovery. This paper will seek to find the answer to these questions. 
This paper will demonstrate the success of microbiome transplantation between recipient and 
donor mice, will explore the trends seen in the composition of the microbiome after stroke, and 
will seek to find a link between the microbiome and stroke outcomes. Being able to successfully 
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and selectively alter the microbiome in an organism to reduce the harmful effects of stroke and 
improve recovery would not only be a completely novel potential direction in stroke research, 
but could offer a plethora of innovative treatment options that could be readily implemented 
through techniques already used for the treatment of Clostridium dificile infection or through 
simple probiotic formulas. This study’s findings could lead to invaluable insights into the 
relationship between the gut, the immune system and the brain and may be able to identify new 
targets to enhance functional recovery after stroke. 
 
Purpose 
This project sought to examine the effect of the microbiome on stroke outcomes after 
experimental stroke in mice. Initial experiments were conducted to confirm reports that marked 
changes can be observed in the microbiota with age and results demonstrated that marked 
differences occur in the microbiome of young vs. aged mice. It is now widely recognized that 
that as organisms’ age, there is a corresponding increase in circulating inflammatory markers. 
This pro-inflammatory milieu makes organisms less able to cope with a variety of stressors, 
including stroke. Aged animals (and humans) have increased mortality and poorer recovery after 
ischemic stroke compared to their young counterparts. Clear differences in the ratio of the two 
major phyla of microbes present in murine microbiomes (Bacteroidetes/Firmicutes) in young vs. 
aged mice were observed, with aged mice presenting microbiome compositions associated with 
harmful health effects. Young animals have a high ratio of Bacteroidetes to Firmicutes while 
aged animals have the opposite. A similar relationship has also been seen in the human 
microbiome. Additionally, it was found that after an experimental stroke the microbiome 
composition of young animals’ changes to resemble the composition of that seen in aged non-
stroke mice. These findings could prove to be of substantial value to stroke research since it has 
already been confirmed by many other studies that high relative abundances of Firmicutes to 
Bacteroidetes (ratios resembling aged animal microbiomes) are tightly correlated to 
hypertension, cardiovascular complications, and obesity; all of which are direct risk factors that 
can both increase the incidence of ischemic stroke as well as dramatically reduce recovery after 
an ischemic event[50-56, 91, 92].  
The goal of these experiments was to examine the effect of transferring a young microbiome into 
an aged animal, to determine if restoring a more “youthful” microbiome will reduce morbidity 
and mortality after stroke. I hypothesized that transplantation of theoretically beneficial 
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microbiome from young mice into aged mice can improve functional recovery in aged recipients 
post-stroke when compared to aged mice that receive aged donor transplants. Using the same 
logic, a group of young mice received aged fecal transplants, which I hypothesized would 
experience worsened stroke outcomes when compared to the young controls. 
 
Materials/Methods 
Mice  
The experiment used a total of 48 male mice. 24 young mice housed at the laboratory following 
birth and were a housed two mice per cage for a period of two months prior to any experimental 
procedures for habituation purposes. 24 aged mice born 4/2013 ordered from The Jackson 
Laboratory were also used in the experiment and were also held in the lab for a 2-month 
habituation period after arrival. At time of the procedure young adult mice were approximately 
two months of age (considered to be equivalent to 18 year old humans) while aged mice were 16 
months of age making them equivalents to 55-60 year old humans. Mice were housed in standard 
mouse cages with suspended wire mesh bottoms to prevent cacophagy. This study was 
conducted in accordance with the National Institute of Health guidelines for the care and use of 
animals in research and under protocols approved by the Center for Lab Animal Care at the 
University of Connecticut Health Center. 
Fecal Transplantation 
3 aged mice and 3 young mice were chosen as donor mice who’s feces would be used for 
microbiome transplants into recipient mice. Fecal pellets from the donor mice were collected and 
placed in 1.0mL of iced phosphate buffered saline solution (PBS). Final volumes were adjusted 
to ensure a concentration of 120 mg donor feces per mL PBS. Sterile wooden toothpicks were 
used to mash fecal pellets in the PBS until a paste-like consistency was reached followed by 
vortexing the solution at maximum speed for a total of 1 minute. The solutions were then 
centrifuged at 800 × g for 3 minutes. The supernatant from the centrifuged solution was then 
removed and used for the transplants into the recipient mice. Protocol was similar to those 
described in previous studies[94, 95]. 
Endogenous gut microbiomes of the recipient mice were suppressed as much as possible prior to 
transplantation via administration of 2 concentrated antibiotic doses. Streptomycin HCl 
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suspended in sterile water at a concentration of 500 mg per mL was used. Each mouse received 
50 µL per dose administered directly into their oral cavities. 24 hours following the initial 
antibiotic dose, the mice received a second dose of the antibiotic to attempt to suppress 
endogenous microbial populations as much as possible.  
Fecal transplants of the supernatants collected from donor feces were administered to recipient 
mice at 24 and 48 hours following the second antibiotic dose. (Figure 3) 
 
 
 
 
 
 
 
 
Fecal Collection  
Fecal samples from mice were collected both prior to experimental procedures and following 
transplantation. To collect samples, mice were removed from cages and individually placed on 
sterile surfaces until they defecated. Stool samples were then collected and placed in sterile tubes 
to be stored at -80° Celsius. Sterile protocol was followed during collection. 70% ethanol was 
used on all surfaces prior to collection and in between mice during stool collections. Gloves were 
changed between each mouse to avoid all potential sources of cross-contamination of samples.  
Experimental Stroke 
Focal transient cerebral ischemia was induced in the experimental mice via a 60 minute 
Habituation, n=48  
-young mice housed at 
UCHC since 7/2014 
-aged mice DOB 
4/2013 
1 month, n=48 
-2 doses concentrated 
streptomycin HCl suspended 
in sterile H2O (500mg/mL) 
-fecal transplants given 24 
and 48 hours after second 
dose of antibiotic  
 
60 minute MCAO 1 month post 
fecal transplant  
D1 Post-
stroke: 
-NDS 
D3 Post-
Stroke: 
-NDS 
-Open Field  
-Hang Wire 
D7 Post-
Stroke: 
-NDS 
-Open Field 
-Hang Wire 
2 wk Post-
Stroke: 
-NDS 
-Open Field 
-Hang Wire 
3 wk Post-
Stroke: 
-NDS 
-Open Field 
-Hang Wire 
 
Pre-train 
for Open 
Field/Hang
wire prior 
to stroke 
Figure 3: Experimental design. Young and aged mice were both held unaltered for a 2 month habituation 
period prior to any experimentation (green section of timeline). After habituation, antibiotics and fecal 
transplants were administered to mice as described. Following transplantation, mice were held in cages for 
1 month to allow for newly transplanted microbiomes to colonize and stabilize in the gut of the recipient 
animals (orange section). At the end of the 1 month post-transplant, mice were pre-trained on behavioral 
tests and at exactly 1 month post-transplant, stroke mice were given experimental 60 minute middle 
cerebral artery occlusions and sham mice were given sham surgeries. Mice were scored for neurological 
deficit at days 1, 3, 7, 14, and 21 post-stroke and were tested via hang wire and open field behavioral tests 
at days 3, 7, 14, and 21. At 3 weeks post-stroke, mice were sacrificed using a 2% Avertin solution at a dose 
of 0.1mL/10g body weight and perfused  with heparinized PBS, followed by 4% paraformaldehyde. Once 
fixed, the brain tissue will be harvested, placed in 30% sucrose until dehydrated. The brains will be 
sectioned into 30μm-thick slices on a microtome and the sections will then be stained using cresyl violet to 
measure and analyze infarct size to compare tissue damage. 
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reversible right middle cerebral artery occlusion under isoflurane anesthesia followed by 
reperfusion as previously described[93]. Silicon coated sutures, 0.21 and 0.23 mm in dimension, 
were used to occlude the middle cerebral arteries of young and aged animals, respectively. 
Throughout the surgery and ischemia mouse rectal muscle temperature was measured and 
monitored using a Monotherm system maintaining body temperature at 37 degrees Celsius via an 
automated feedback mechanism. Sham mice underwent the same procedure except sutures were 
not advanced into the middle cerebral arteries for occlusion. The model provided for a consistent 
model of ischemia in the murine brain that was uniform throughout the cohort. Following 
ischemic stroke, all animals were given 0.2 mL saline injections subcutaneously for the first 
week following the procedure along with free access to wet mashed food to ensure survival 
Behavioral Testing  
Prior to all behavioral testing, all mice were acclimated for 1 hour in the testing rooms in their 
home cages. Sterile protocol was followed with the testing rooms and equipment. All equipment 
was cleaned with 70% ethanol in between trials and in between mice. Tests were conducted at 
the same time of day each time they were administered for consistency. Animals were pre-
trained on all tests prior to stroke to assess baseline scores for all the mice. 
Neurological Deficit Scoring 
Neurological deficit scores (NDS) were collected before and after stroke. Score was taken 
immediately following stroke at reperfusion, 1 day post-stroke, and at days 3, 7, 14, and 21 post-
stroke as shown in the experimental design in Figure 3. The score is determined using a 5-point 
scale: 0, no deficit; 1, forelimb weakness and torso turning to the ipsilateral side when held by 
tail; 2, circling to affected side; 3, unable to bear weight on affected side; 4, no spontaneous 
locomotor activity or barrel rolling. 
Open Field Test 
The open field test is administered to mice to assess general locomotor activity. The starting 
placement of each mouse's trial was in the front right corner of a clear, acrylic box (16 inches by 
16 inches). Once placed in the starting spot, each mouse was allotted a 10 minute interval, during 
which it was completely free to roam and explore the enclosed area. Activity was quantified 
using a computer operated PAS open field system computer program (San Diego Instruments, 
San Diego, CA). Locomotor activity was measured as the total number of laser beam breaks 
within the area as the mouse moved about. The test was administered to the mice prior to stroke 
 to assess basal levels of movement and
Hang Wire Test 
The hang wire test assesses the sensorimotor functions in mice. A wire cage top of dimensions 
18 inches by 9 inches was used for the procedure. Mice were placed on top of the cage in the 
center, and the wire lid was then slowly inverted and placed at a height of 9 inches above an 
empty cage bottom containing regular bedding. The time between inversion to the moment the 
mouse fell from the inverted cage was measured. A total of three trials was used 
a 45 minute gap in between each trial. The average of the three trials was then compared to the 
latency to fall measured at baseline for each mouse.
Cresyl Violet Staining 
After sacrifice, brains of each mouse were harvested, 
The brains will be sectioned into 30
stained using cresyl violet to measure and analyze infarct size to compare tissue damage.
Statistics 
All values are expressed as mean±SEM and analyze
assessments were performed by a blinded investigator. The 
was P<0.05. 
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Figure 4: Sequencing data from 
samples collected from Aged and 
Young mice. Breakdown of fecal 
sample composition at the phylum 
level. Samples collected prior to any 
experimental treatment during 
habituation periods to assess basal 
levels of microbial compo
between the groups of mice. 
Data confirmed previous reports 
stating that  >90% of the gut 
microbiome is composed of 
Firmicutes and Bacteroidetes phyla. 
Trends of an increasing Firmicutes 
to Bacteroidetes
with increasing age as previously 
reported by other studies.  
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Prior to any experimental procedures, fecal samples were collected from aged donor mice and 
young donor mice for purposes of confirming previous reports on microbial compositions. 
Sequencing data confirmed reports of gut microbiomes being >90% composed of two phyla 
(Bacteroidetes/Firmicutes). As shown in Figure 4, young microbiome samples displayed high 
Bacteroidetes/Firmicutes ratios, with Bacteroidetes(in blue) composing roughly 65% of the 
microbiome on average. Aged mice, demonstrated the opposite ratio with much greater 
abundances of Firmicutes(in red). Interestingly enough, young samples contained larger portions 
of Verrucomicrobia within their microbiomes, with the phyla varying in abundances between 8-
9% in the animals while the phyla was virtually unseen in aged samples at abundances of nearly 
zero in most animals while the aged animals showing the highest abundances never contained 
more than 4% of the phyla. Many of the aged animals also contained a presence of 
Deferribacteres while nearly all young samples contained no detectable presence of the phyla.   
Microbiome Transplants  
 
The experimental procedure required various control groups to control for antibiotics, the 
transplant procedures, and then stroke surgeries. As shown by Table 2, the aged and young mice 
were broken down into 4 main transplant groups: 1, young mice receiving young microbiomes; 
2, young mice receiving aged microbiomes; 3, aged mice receiving aged microbiomes; 4, aged 
mice receiving young microbiomes. The aged and young mice that received microbiome 
transplants from their own respective age group were the control groups for any differences that 
could have arisen from the antibiotics or transplant procedures themselves. The 4 main transplant 
Aged Mice Stroke Sham 
Young fecal transplant n=8 n=4 
Aged fecal transplant (control) n=8 n=4 
total n=16 n=8 
Young Mice 
Young fecal transplant (control) n=8 n=4 
Aged fecal transplant  n=8 n=4 
total n=16 n=8 
Total     
n=48 mice (24 young/24 aged) 32 strokes 16 shams  
4 Types of Fecal Transplants carried out: 
1. Young donorYoung recipients (control) 
2. Young donorAged recipient 
3. Aged donorAged recipient (control) 
4. Aged donorYoung recipient  
 Table 2: (on left) the breakdown of the basic groups used 
in experimental design. A total of 8 separate groups were 
used to give a total n of 48 mice. Different transplant 
groups were divided into stroke and sham groups, sham 
surgeries as controls. (on right) the 4 types of microbiome 
transplants that were used in the experimental design. 2 
controls groups were used to control for antibiotic 
treatment and the transplant procedures themselves.  
 groups were then further broken down into mice that would receive stroke surgeries and mice 
that would only receive sham surgeries to control for the surgical procedure. 
Figure 5: (on left) on top is the sequencing data of fecal samples from donor mice that were used, as shown on a 
larger scale in Figure 4. Below is the sequencing data of fecal samples collected from young and aged reciepient 
mice that received microbiomes from their own respective age group. (on right) donor data depicted on top for 
comparison purposes again, below is sequencing data of fecal samples from young mice receiving aged microbiome 
transplants and aged mice receiving young microbiome transplants.
transplantation could be seen in clear transmission of the Bacteroidetes/Firmicutes ratio
recipients 1 month following transplant.
Figure 5 depicts sequencing data at a phylum level of fecal samples c
aged recipient mice 1 month after microbiome transplantation. Young controls showed 
successful transplantation from young donor mice, showing clear similarities in microbial 
composition to donors as well as successful transmission o
Bacteroidetes/Firmicutes ratio. Aged mouse controls showed the same results except with the 
opposite microbial ratio, displaying low 
aged microbial populations. Sequencing data of feca
recipient mice 1 month following transplantation showed successful transmission of the 
Bacteroidetes/Firmicutes ratio of interest from donors to recipients. 
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 the low ratio that was commonly seen in Aged mice.
Deferribacteres phyla could also be observed that was greater than in any young controls and 
donors. Data from fecal samples taken from Aged mice than underwent successful transplants 
from Young mice also showed a common trend of reversal in the 
The resulting high ratio resembled that of young donors and greatly exceeded any of the ratios 
seen in Aged donors/controls. An extraordinary elevation in the 
commonly seen in the Aged mice receiving young fecal transp
controls/donors (Figure 6).  
Figure 6: Relative abundances of Bacteroidetes/Firmicutes in mice following fecal transplantation. Marked 
elevation of Bacteroidetes in mice receiving young microbiomes while the opposite is t
microbiome transplant. Previously reported aged dependent ratios of Bacteroidetes/Firmicutes microbes were 
observed in mice receiving transplants. 
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Figure 7a: Neurological deficit 
scores of young mice post
Prior to reperfusion all animals 
scored 0 on the NDS scale, 
indicating no basal levels of 
neurological deficit. 
Following stroke, significantly 
improved recovery was seen in 
young mice with gut microbiomes 
of young donors recovering after 
3 weeks. Young mice that
received the microbiomes of aged 
donors demonstrated markedly 
reduced recovery and never fully 
returned to basal levels of no 
neurological deficit. 
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 Microbiome composition seemed to have a significant impact on recovery from neurological 
deficit in young mice (Figure 7a). Young mice that received young microbiota had markedly 
improved recovery times after stroke according to their NDS scores compared to the mice that 
received aged transplants. The mice that received young microbial compositions also 
demonstrated full functional recovery at 3 weeks whereas the animals that contained aged 
microbiome never fully recovered from ischemia. 
A significant difference in functional recovery wasn’t seen in aged mice regardless of 
microbiome composition (Figure 7b
to form as aged mice containing aged microbiomes seemed to be on track to fully recover while 
recipients of aged microbiota appeared to plateau in their recovery suggesting a lack of full 
functional recovery. The study would need to be repeated, however, with increased survival 
times prior to sacrifice to confirm this observation. 
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). 1 week post-stroke, however, a difference in trends began 
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Figure 7b: Neurological deficit scores 
of aged mice obtained following 
stroke. All animals had basal scores of 
0 prior to stroke indicating no 
neurological deficit prior to ischemia. 
No significant differences between 
aged mice receiving aged and young 
microbiomes were observed. 
No full recovery was seen at 3 weeks 
as it was with young mice, however. 
The final overall trend of recovery 
suggested full functional recovery of 
aged mice that received young 
microbiomes while aged mice 
containing aged microbiom
appeared to be trending to never fully 
functionally recover. 
Figure 8a: Latency to fall 
during hang wire test for 
aged mice post
Mice tested pre
then 3, 7, 14, and 21 
days after stroke. Aged 
mice that received young 
microbiome transplants 
outperformed 
mice that received 
microbiome transplants 
from aged donors. 
Differences in 
performance were 
dramatically amplified 
by stroke. 
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 Figures 8a and 8b depict the data collected from aged mice that underwent stroke surgery 
(Figure 8a) and those that underwent sham surgery (Figure 8b). In both groups, aged mice 
that received young microbiome transplants 
depicted by their increased latencies to fall. Aged mice that received transplants from 
young donors had improved performances on the hang wire test as compared to those that 
received transplants from aged donors a
differences were found to be further amplified following stroke when measured at 3 weeks 
whereas the differences in performance stayed relatively stable in sham surgery mice. 
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Figure 8b:Latency
during the hang wire test for 
aged mice that received 
sham surgeries instead of 
middle cerebral artery 
occlusions. Mice with young 
microbiomes outperformed 
those with aged microbiomes 
but at 3 weeks post
the differences were roughly 
the sa
to surgery. 
Figure 9a: Latency to fall 
during 
young mice that 
underwent ischemic stroke. 
Mice with young 
microbiomes outperformed 
those with aged 
microbiomes. Stoke 
appeared to amplify the 
differences at 2 weeks post 
stroke but the two groups 
were closer in performance 
by 3 weeks po
30
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me as they were prior 
 
hang wire test for 
st-stroke. 
 Trends noticed in aged animals were also seen in young mice except on
animals that received microbiota of aged animals had a markedly decreased latency to fall as 
compared to mice that received transplants from young donors during initial phases of recovery 
as seen by the marked differences in fall la
stroke, however, all young animals had nearly the same performance on the hang wire test, 
mirroring the recovery of young mice as seen in the NDS data. 
Figure 11: Latency to fall on the hang wire test of young and aged mice at pre
stroke. Pre-stroke young mice outperformed aged mice, however the young mice that were the recipients of 
microbiome transplants from young donors outperformed young mice that received transplants from aged donors. 
A similar trend within the aged mice was seen with the young microbiome recipients outperformed aged 
microbiome recipients. At 2 weeks post
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-stroke, the differences within age groups were significantly amplified. 
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Figure 9b: Latency to fall 
on the hang wire test 
following sham surgeries. 
Similar differences in 
performance as in other 
groups, young 
microbiomes 
outperforming aged. 
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Open Field Test/CV Analysis 
Figure 12: Open field data collected from mice following stroke. No significant differences were found between any 
of the groups during trials. As shown in the figure, large variation was seen 
observed.   
No significance was found in the results of the open field test or during CV staining/analysis of 
the harvested brains following stroke. Perhaps a larger n is required to see trends or perhaps the 
microbiome has no impact on infarct volume. Open field test would need to be repeated again 
with a larger n since the results seem to contradict the collected data from the hang wire tests and 
NDS.  
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in the cohort and no clear trends were 
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Figure 13: Cresyl violet staining of harvested mouse 
brains 3 weeks post-stroke. Infarct volume did not 
appear to be dependent on microbiome 
composition. Infarct volume of young mice was 
significantly larger than that of aged mice, as has 
been reported in the literature.   
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Discussion 
The experimental results clearly showed encouraging trends linking the microbiome to 
functional recovery following ischemic stroke. As it has been reported in the literature, 
microbiome samples collected via the feces confirmed the phylum-level differences between 
aged and young organisms. Young microbiomes seem to contain a high Bacteroidetes/Firmicutes 
ratio while the opposite is true for aged mice(Figure 6). The low ratio, as present in aged 
animals, has been linked to various risk factors for stroke and diseased conditions in the 
literature, which formed the basis of the hypothesis that this “harmful” population of microbes 
could potentially hinder functional recovery in young animals following stroke while giving then 
“beneficial” microbiome of young animals to aged animals could help positively impact 
functional recovery following stroke[8-17].  
The NDS and hang wire test results helped support this hypothesis by suggesting the young 
microbiome can protective or encouraging of functional recovery in both young and aged 
animals. Both young and aged mice that received aged microbiome transplants demonstrated 
decreased recovery based on the NDS and hang wire test results. The differences in the animals 
were present pre-stroke, but were dramatically amplified and obvious following ischemia, 
suggesting that perhaps the aging microbiome doesn’t play a major role until some sort of 
stressor is present, at which point young microbiomes can confer protective benefits while the 
aged microbiome lacks the capacity to do so.  
The low Bacteroidetes/Firmicutes ratio has been linked to increased circulation of inflammatory 
markers, cardiovascular risk, tendency for obesity; all risk factors for stroke[30-68, 91, 92]. This has 
proven harmful to multiple inflammatory diseases, so it is not much of a stretch to expect the 
ratio to have a negative impact on a cardiovascular disease like ischemic stroke. Stroke has been 
also linked to cause an increase in gut permeability, and “leaky gut” syndrome has commonly 
been linked to disease and harmful effects on host health following gut microbe translocation and 
the transmission of microbe metabolic products into systemic circulation[77-80]. The combination 
of leaky gut post-stroke and harmful metabolic products resulting from the relatively high 
Firmicute abundance in the aged microbiome could be the explanation for worsened recovery in 
animals containing the aged microbiome post-stroke. It could also help explain the reason for the 
nearly non-existent differences between groups prior to stroke, whereas following ischemia there 
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are dramatic behavioral differences. This could also explain why animals containing a high 
Bacteroidetes/Firmicutes ratio seem to be more protected from stroke and demonstrated 
improved recovery since they have been reported to confer protective benefits to the host and 
promote up-regulation for proteins in tight endothelial junction (which could help protect from 
leaky gut or blood-brain barrier breaches), promote improved responses to stress in terms of a 
less overactive stress response, and help prevent large inflammatory responses by the innate 
immune system[50-56, 70, 90-92] .  
It was disappointing to not observe any of the same trends in the open field test. Unfortunately, 
no significant results were collected from the test, which failed to further support the hypothesis 
of the young microbiome being conducive of functional recovery post-stroke while the aged 
microbiome is harmful. Aged and young organisms are known to have different infarct volumes 
following ischemic attack. While young animals typically experience greatly improved 
functional recovery after stroke than their aged counterparts, the young mice typically have much 
larger infarct volumes in their brains. CV staining and analysis did not demonstrate any positive 
or negative impacts of microbiome composition in the experimental mice.  
While these results are very promising and inspiring, since the trends are very clear in the NDS 
and hang wire results and are theoretically supported by the literature, much more work will need 
to be done in the future to elucidate the exact link between the microbiome and ischemic stroke. 
While the n of 48 was a fairly large number, there was still a fair amount of variation observed in 
the data so the n will have to be greatly increased and further tests will need to be conducted. The 
open field test should be repeated on a larger scale to find trends that could potentially exist that 
were overlooked. A longer survival time of 4-6 weeks should be used for following cohorts to 
allow for a greater window of time to see the development of the trends that were seen during 
these experiments. While the tests that were used with this cohort gave glimpses into the motor 
impacts of the microbiome on stroke recovery, it would be interesting to expand the pool of 
behavioral tests to more cognitive-based tests such as the novel object recognition test which 
tests the learning and memory or elevated maze tests that test the animals for anxiety. All these 
thoughts will be put into consideration for future experimentation to create a full test of the 
microbiome’s impact on an organisms motor and cognitive recovery following ischemic stroke. 
The results reported here, though, give invaluable insight into this novel area of research offering 
support that the microbiome does, in fact, play some role in functional recovery of mice.  
Using the data reported here, the hope will be to see similar trends in future data. If successful, 
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these results could truly prove to be monumental, offering totally new potential avenues for 
stroke treatment and prevention.  
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